Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

TrimTabs and BarclayHedge report hedge fund inflows of $817m in March

Wednesday, May 08, 2013
Opalesque Industry Update - BarclayHedge and TrimTabs Investment Research report that hedge funds took in a net $817 million (0.04% of assets) in March, building on an inflow of $11.4 billion in February. The results are based on data from 3,409 funds.

“The hedge fund industry continues to struggle with performance relative to the S&P 500,” said Sol Waksman, president and founder of BarclayHedge. “The industry delivered a return of 1.1% in March, less than one-third of the S&P 500’s 3.6% rise. Although hedge funds delivered positive returns in 10 of the past 12 months, they trailed the S&P 500 by 450 basis points."

The TrimTabs/BarclayHedge Hedge Fund Flow Report noted that stock-picking hedge fund managers performed well in March, just as they did in the first two months of this year.

“Equity Long Only hedge funds rose 3.3% in March, making them the best performing of 13 major fund categories,” said Waksman. “Fixed Income and Multi Strategy were the only strategies that posted inflows in the past 12 months."

Funds of hedge funds continued to shed assets, losing $2.6 billion in February and $53.2 billion in the past 12 months. They underperformed the hedge fund industry by 230 basis points in the past 12 months.

The latest TrimTabs/BarclayHedge Survey of Hedge Fund Managers found managers are worried about the stock market’s prospects for May. Opinions on 10-year Treasuries and several other indicators suggest hedge fund managers are bearish.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V